Filing Details
- Accession Number:
- 0001209191-21-023066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-25 17:32:43
- Reporting Period:
- 2021-03-23
- Accepted Time:
- 2021-03-25 17:32:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1789769 | Instil Bio Inc. | TIL | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1750117 | Vivo Capital Fund Ix, L.p. | 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No | |
1750698 | Vivo Capital Ix, Llc | 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-23 | 11,709,696 | $0.00 | 11,709,696 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2021-03-23 | 477,091 | $0.00 | 12,186,787 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2021-03-23 | 300,000 | $20.00 | 12,486,787 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2021-03-23 | 9,758,080 | $0.00 | 11,709,696 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2021-03-23 | 397,576 | $0.00 | 477,091 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.
- The securities are held by Vivo Capital Fund IX, L.P. ("Fund IX"). Vivo Capital IX, LLC ("Capital IX") is the general partner of Fund IX. As themanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang sharevoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent oftheir individual pecuniary interest therein.